[Fertility preservation]

Area of Science:

• Reproductive Medicine
• Oncology
• Genetics

Background:

• Cancer treatments such as chemotherapy and radiotherapy can impair ovarian and testicular function, leading to reduced or absent gamete production.
• Improved cancer prognoses necessitate strategies to mitigate treatment-related infertility.
• Fertility preservation is crucial for restoring reproductive capabilities in cancer survivors.

Purpose of the Study:

• To outline the importance and methods of fertility preservation in patients undergoing treatments with potential gonadal toxicity.
• To describe the role of the French national sperm banking network (CECOS) in managing fertility preservation techniques.

Main Methods:

• Fertility preservation involves cryopreservation of gametes (oocytes, spermatozoa), embryos, and germinal tissues (ovarian and testicular tissue).
• Techniques aim to safeguard reproductive potential for future use.
• The CECOS network provides a coordinated national approach to these procedures.

Main Results:

• Fertility preservation offers a viable option for patients to retain the possibility of biological parenthood after cancer treatment.
• The CECOS network centralizes and standardizes fertility preservation services across France.
• Successful implementation of these techniques can significantly improve the quality of life for cancer survivors.

Conclusions:

• Fertility preservation is an essential component of comprehensive cancer care, addressing the long-term well-being of patients.
• Coordinated national networks like CECOS are vital for ensuring equitable access to and standardized delivery of fertility preservation services.
• Further research and development in cryobiology and assisted reproductive technologies will continue to enhance fertility restoration outcomes.